GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Other Current Payables

IMGT (XKRX:456570) Other Current Payables : ₩2,328.98 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is IMGT Other Current Payables?

IMGT's Other Current Payables for the quarter that ended in Dec. 2023 was ₩2,328.98 Mil.

IMGT's quarterly Other Current Payables increased from Dec. 2021 (₩0.00 Mil) to Dec. 2022 (₩958.66 Mil) and increased from Dec. 2022 (₩958.66 Mil) to Dec. 2023 (₩2,328.98 Mil).

IMGT's annual Other Current Payables increased from Dec. 2021 (₩0.00 Mil) to Dec. 2022 (₩958.66 Mil) and increased from Dec. 2022 (₩958.66 Mil) to Dec. 2023 (₩2,328.98 Mil).


IMGT Other Current Payables Historical Data

The historical data trend for IMGT's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Other Current Payables Chart

IMGT Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Current Payables
- - 958.66 2,328.98

IMGT Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Other Current Payables - - 958.66 2,328.98

IMGT Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


IMGT Other Current Payables Related Terms

Thank you for viewing the detailed overview of IMGT's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


IMGT (XKRX:456570) Business Description

Traded in Other Exchanges
N/A
Address
172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605
IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT (XKRX:456570) Headlines

No Headlines